156 related articles for article (PubMed ID: 6186413)
1. 2,6-Dimethyloctanedioic acid--a metabolite of phytanic acid in Refsum's disease.
Greter J; Lindstedt S; Steen G
Clin Chem; 1983 Mar; 29(3):434-7. PubMed ID: 6186413
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of phytanic acid in Refsum's disease.
Billimoria JD; Clemens ME; Gibberd FB; Whitelaw MN
Lancet; 1982 Jan; 1(8265):194-6. PubMed ID: 6172683
[No Abstract] [Full Text] [Related]
3. Occurrence of novel branched-chain fatty acids in Refsum's disease.
Dulaney JT; Williams M; Evans JE; Costello CE; Kolodny EH
Biochim Biophys Acta; 1978 Apr; 529(1):1-12. PubMed ID: 76480
[TBL] [Abstract][Full Text] [Related]
4. Refsum's disease and metabolism of phytanic acid.
Stokke O; Refsum S
Lancet; 1982 Apr; 1(8277):906-7. PubMed ID: 6175864
[No Abstract] [Full Text] [Related]
5. Infantile Refsum's disease (phytanic acid storage disease): a variant of Zellweger's syndrome?
Poulos A; Sharp P; Whiting M
Clin Genet; 1984 Dec; 26(6):579-86. PubMed ID: 6209040
[TBL] [Abstract][Full Text] [Related]
6. Fatty acid composition of tissues in Refsum's disease (herodopathia atactica polyneuritiformis). Estimation of total phytanic acid accumulation.
Malmendier CL; Jonniaux G; Voet W; Van Den Bergen CJ
Biomedicine; 1974 Nov; 20(6):398-407. PubMed ID: 4141904
[No Abstract] [Full Text] [Related]
7. Disorders related to the metabolism of phytanic acid.
Stokke O; Skjeldal OH; Høie K
Scand J Clin Lab Invest Suppl; 1986; 184():3-10. PubMed ID: 2438746
[TBL] [Abstract][Full Text] [Related]
8. Phytanic acid alpha-oxidation and complementation analysis of classical Refsum and peroxisomal disorders.
Poll-The BT; Skjeldal OH; Stokke O; Poulos A; Demaugre F; Saudubray JM
Hum Genet; 1989 Jan; 81(2):175-81. PubMed ID: 2463966
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial oxidation of phytanic acid in human and monkey liver: implication that Refsum's disease is not a peroxisomal disorder.
Watkins PA; Mihalik SJ
Biochem Biophys Res Commun; 1990 Mar; 167(2):580-6. PubMed ID: 1690986
[TBL] [Abstract][Full Text] [Related]
10. Evidence against alpha-hydroxyphytanic acid as an intermediate in the metabolism of phytanic acid.
Skjeldal OH; Stokke O
Scand J Clin Lab Invest; 1988 Feb; 48(1):97-102. PubMed ID: 2464193
[TBL] [Abstract][Full Text] [Related]
11. Clinical and biochemical heterogeneity in conditions with phytanic acid accumulation.
Skjeldal OH; Stokke O; Refsum S; Norseth J; Petit H
J Neurol Sci; 1987 Jan; 77(1):87-96. PubMed ID: 2433405
[TBL] [Abstract][Full Text] [Related]
12. Phytanic acid oxidase activity in cultured skin fibroblasts. Diagnostic usefulness and limitations.
Skjeldal OH; Stokke O; Norseth J; Lie SO
Scand J Clin Lab Invest; 1986 May; 46(3):283-7. PubMed ID: 2424078
[TBL] [Abstract][Full Text] [Related]
13. Infantile phytanic acid storage disease, a possible variant of Refsum's disease: three cases, including ultrastructural studies of the liver.
Scotto JM; Hadchouel M; Odievre M; Laudat MH; Saudubray JM; Dulac O; Beucler I; Beaune P
J Inherit Metab Dis; 1982; 5(2):83-90. PubMed ID: 6188882
[TBL] [Abstract][Full Text] [Related]
14. Tissue distribution of phytanic acid and its analogues in a kinship with Refsum's disease.
Yao JK; Dyck PJ
Lipids; 1987 Feb; 22(2):69-75. PubMed ID: 2436023
[TBL] [Abstract][Full Text] [Related]
15. 3-Methyladipate excretion in animals fed a phytol supplement with reference to Refsum's disease.
Krywawych S; Brenton DP; Jackson MJ; Forte C; Walker DK; Lawson AM
J Inherit Metab Dis; 1985; 8 Suppl 2():147-8. PubMed ID: 2413274
[No Abstract] [Full Text] [Related]
16. 3-Methyladipate excretion in Refsum's disease.
Brenton DP; Krywawych S
Lancet; 1982 Mar; 1(8272):624. PubMed ID: 6174838
[No Abstract] [Full Text] [Related]
17. Phytanic acid and very long chain fatty acids in genetic peroxisomal disorders.
Molzer B; Kainz-Korschinsky M; Sundt-Heller R; Bernheimer H
J Clin Chem Clin Biochem; 1989 May; 27(5):309-14. PubMed ID: 2474624
[TBL] [Abstract][Full Text] [Related]
18. Peroxisomes, Refsum's disease and the alpha- and omega-oxidation of phytanic acid.
Wanders RJ; Komen JC
Biochem Soc Trans; 2007 Nov; 35(Pt 5):865-9. PubMed ID: 17956234
[TBL] [Abstract][Full Text] [Related]
19. Heredopathia atactica polyneurotiformis: therapeutic and pathogenetic aspects.
Refsum S
Riv Patol Nerv Ment; 1976 Jun; 97(3):115-26. PubMed ID: 74082
[TBL] [Abstract][Full Text] [Related]
20. CYP4 isoform specificity in the omega-hydroxylation of phytanic acid, a potential route to elimination of the causative agent of Refsum's disease.
Xu F; Ng VY; Kroetz DL; de Montellano PR
J Pharmacol Exp Ther; 2006 Aug; 318(2):835-9. PubMed ID: 16707724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]